BioGaia AB (publ) (LON:0GTN)

BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of GBP 849.51 million. The enterprise value is 791.56 million.

Market Cap	849.51M
Enterprise Value	791.56M

Important Dates

The last earnings date was Tuesday, October 21, 2025.

Earnings Date	Oct 21, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	98.50M
Shares Outstanding	n/a
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.19%
Owned by Institutions (%)	43.27%
Float	70.71M

Valuation Ratios

The trailing PE ratio is 34.06 and the forward PE ratio is 26.93.

PE Ratio	34.06
Forward PE	26.93
PS Ratio	7.36
PB Ratio	8.83
P/TBV Ratio	10.08
P/FCF Ratio	33.37
P/OCF Ratio	33.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.35, with an EV/FCF ratio of 31.10.

EV / Earnings	31.74
EV / Sales	6.80
EV / EBITDA	24.35
EV / EBIT	25.99
EV / FCF	31.10

Financial Position

The company has a current ratio of 6.27

Current Ratio	6.27
Quick Ratio	4.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	51.40

Financial Efficiency

Return on equity (ROE) is 22.26% and return on invested capital (ROIC) is 16.85%.

Return on Equity (ROE)	22.26%
Return on Assets (ROA)	14.10%
Return on Invested Capital (ROIC)	16.85%
Return on Capital Employed (ROCE)	29.17%
Revenue Per Employee	502,000
Profits Per Employee	108,443
Employee Count	225
Asset Turnover	0.86
Inventory Turnover	n/a

Taxes

In the past 12 months, BioGaia AB has paid 6.81 million in taxes.

Income Tax	6.81M
Effective Tax Rate	21.44%

Stock Price Statistics

The stock price has increased by +5.31% in the last 52 weeks. The beta is 0.66, so BioGaia AB's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+5.31%
50-Day Moving Average	104.43
200-Day Moving Average	107.96
Relative Strength Index (RSI)	64.58
Average Volume (20 Days)	17,845

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of GBP 115.46 million and earned 24.94 million in profits. Earnings per share was 0.25.

Revenue	115.46M
Gross Profit	83.95M
Operating Income	30.21M
Pretax Income	31.75M
Net Income	24.94M
EBITDA	31.55M
EBIT	30.21M
Earnings Per Share (EPS)	0.25

Balance Sheet

The company has 57.48 million in cash and n/a in debt, giving a net cash position of 57.48 million.

Cash & Cash Equivalents	57.48M
Total Debt	n/a
Net Cash	57.48M
Net Cash Per Share	n/a
Equity (Book Value)	96.16M
Book Value Per Share	0.95
Working Capital	72.96M

Cash Flow

In the last 12 months, operating cash flow was 25.67 million and capital expenditures -218,063, giving a free cash flow of 25.46 million.

Operating Cash Flow	25.67M
Capital Expenditures	-218,063
Free Cash Flow	25.46M
FCF Per Share	n/a

Margins

Gross margin is 72.71%, with operating and profit margins of 26.16% and 21.60%.

Gross Margin	72.71%
Operating Margin	26.16%
Pretax Margin	27.50%
Profit Margin	21.60%
EBITDA Margin	27.32%
EBIT Margin	26.16%
FCF Margin	22.05%

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.51%.

Dividend Per Share	0.54
Dividend Yield	0.51%
Dividend Growth (YoY)	5.77%
Years of Dividend Growth	1
Payout Ratio	61.13%
Buyback Yield	-0.17%
Shareholder Yield	0.34%
Earnings Yield	2.94%
FCF Yield	3.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5